| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/27/2002 | WO2002050246A2 Treatment of bone disorders by modulation of fgfr3 |
| 06/27/2002 | WO2002050122A2 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | WO2002050119A2 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | WO2002050115A1 Modified tachykinin receptors |
| 06/27/2002 | WO2002050108A2 Immunogenic glycopeptides, screening, preparation and uses |
| 06/27/2002 | WO2002050107A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | WO2002050106A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | WO2002050101A1 Retinoblastoma-binding protein |
| 06/27/2002 | WO2002050096A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | WO2002049939A1 Method of sampling and an associated product |
| 06/27/2002 | WO2002049761A2 Automated laboratory system and method |
| 06/27/2002 | WO2002049662A2 Use of the prion protein (prp) for suppression of bax-mediated apoptosis |
| 06/27/2002 | WO2002049634A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect |
| 06/27/2002 | WO2002049625A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | WO2002049576A2 Fab i and inhibition of apicomplexan parasites |
| 06/27/2002 | WO2002049507A1 Analyte measurement |
| 06/27/2002 | WO2002049502A2 Methods for diagnosing and treating pediatric neoplasms |
| 06/27/2002 | WO2002024071A3 Method, apparatus and system for assessing hair condition |
| 06/27/2002 | WO2002020822A3 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/27/2002 | WO2002016548A3 Novel g protein-coupled receptor |
| 06/27/2002 | WO2002016433A3 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 06/27/2002 | WO2002016415A3 Identification of a cam-kinase ii inhibitor |
| 06/27/2002 | WO2002012543A3 Two coloured fluorimetric protease assay |
| 06/27/2002 | WO2002010756A3 Diagnosis and treatment of non-ulcer dyspepsia based on hypothalamic-pituitary-adrenal axis abnormality |
| 06/27/2002 | WO2002009868A3 Apparatus for generating a temperature gradient and methods for using the gradient to characterize molecular interactions |
| 06/27/2002 | WO2002006852A3 Programmable microwave back-up warning system and method |
| 06/27/2002 | WO2002006821A3 Antimicrobial agent |
| 06/27/2002 | WO2002006820A3 Method for carrying out a saliva analysis |
| 06/27/2002 | WO2002006524A3 A method for direct genetic analysis of target cells by using flourescence probes |
| 06/27/2002 | WO2002004655A3 Cation mediated triplex hybridization assay |
| 06/27/2002 | WO2002000882A3 Transport peptides dirived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 06/27/2002 | WO2001096830A3 Pathology grossing board |
| 06/27/2002 | WO2001092473A3 Method for cultivating a cartilage replacement and a biomatrix produced according to this method |
| 06/27/2002 | WO2001089383A3 System for removing body fluid, especially blood |
| 06/27/2002 | WO2001087938A3 Polynucleotide sequence encoding a putative cell adhesion molecule |
| 06/27/2002 | WO2001086266A9 Pd/v2 05 device for colorimetric h2 detection |
| 06/27/2002 | WO2001085978A3 Method for high-throughput lead profiling |
| 06/27/2002 | WO2001081921A3 Use of ink-jet printing to produce diffraction-based biosensors |
| 06/27/2002 | WO2001077375A3 Diagnosis of diseases associated with gene regulation |
| 06/27/2002 | WO2001072293A3 Antiprogestins with partial agonist activity |
| 06/27/2002 | WO2001071035A3 Method and apparatus for automatic pin detection in microarray spotting instruments |
| 06/27/2002 | WO2001070978A3 Polypeptides and nucleic acids encoding same |
| 06/27/2002 | WO2001057518A3 Method of non-targeted complex sample analysis |
| 06/27/2002 | WO2001050134A3 Methods of detection of amyloidogenic proteins |
| 06/27/2002 | WO2001046690A3 Method for establishing neurologically relevant properties of a material |
| 06/27/2002 | WO2001044816B1 Conformational and topological protein regulation |
| 06/27/2002 | WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 06/27/2002 | WO2000077238A9 Heterodimeric opioid g-protein coupled receptors |
| 06/27/2002 | WO2000071561A9 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 06/27/2002 | WO2000070541A9 Transformation of digital images |
| 06/27/2002 | WO2000063701A9 Microarrays of polypeptides |
| 06/27/2002 | WO2000062105A9 Reflectively coated optical waveguide and fluidics cell integration |
| 06/27/2002 | US20020082797 Analyte test instrument having improved calibration and communication processes |
| 06/27/2002 | US20020082490 Microdialysis system |
| 06/27/2002 | US20020082413 PGC-1, a novel brown fat PPARgamma coactivator |
| 06/27/2002 | US20020082412 Methods |
| 06/27/2002 | US20020082397 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 06/27/2002 | US20020082394 Treating a cancer; obtain polypeptide coded by tumor gene, administer to human, monitor human for reduction in tumors |
| 06/27/2002 | US20020082392 Antibodies to cell-cycle regulatory proteins, and uses related thereto |
| 06/27/2002 | US20020082391 Polypeptide; for use in enhancement of drug absorption across epithelial and endothelial barriers |
| 06/27/2002 | US20020082301 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 06/27/2002 | US20020082297 Composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease |
| 06/27/2002 | US20020082296 Use in modulation and immunoregulation of an immune response towards infection with mycobacteria in humans and animals; anti-tuberculosis treatment; arthritis treatment; diagnosis |
| 06/27/2002 | US20020082287 Administering a prostaglandin receptor EP4 subtype antagonist; treating bone disorders such as osteoporosis and Paget's disease; works by inhibiting the bone resorption of the osteoclasts |
| 06/27/2002 | US20020082269 Purine-2,6-dione based compounds as receptor binding assay probes and pharmaceuticals; high potency and affinity with water solubility |
| 06/27/2002 | US20020082241 Adenosine as antithrombotic |
| 06/27/2002 | US20020082239 Administering a 6- mercaptopurine drug to a patient having immune-mediated gastrointestinal disorder and determining a level of 6-thioguanine in the patient |
| 06/27/2002 | US20020082234 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020082223 Administering to a patient a therapeutically effective amount of a steroidal glycoside or mixture to treat cancer |
| 06/27/2002 | US20020082216 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 06/27/2002 | US20020082213 Administering Orphanin FQ or a pharmacologically active derivative thereof in daily dosage of 0.1 nanograms-0.1 milligrams per kilogram body weight |
| 06/27/2002 | US20020082202 Screening methods using ligands of the neutropeptide receptor HFGAN72 |
| 06/27/2002 | US20020082193 Inhibition of mitochondrial calcium/sodium antiporter |
| 06/27/2002 | US20020082192 Contacting cell with compound that activates extracellular signal regulated kinase, p42/44MAPK, wherein activation of kinase results in induction of low density lipoprotein receptor expression; treatment of hypercholesterolemia |
| 06/27/2002 | US20020082190 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders |
| 06/27/2002 | US20020081751 Spheres; for use in the color separation |
| 06/27/2002 | US20020081749 Electrical excitation of label substances at insulating film-coated conductors |
| 06/27/2002 | US20020081745 Evaluating psychological and nervous system disorders; obtain human, have human breathe into gas chromatogram, monitor presence of butane desorbed onto matrix |
| 06/27/2002 | US20020081744 Methods and apparatuses for characterization of single polymers |
| 06/27/2002 | US20020081743 Image analysis of urine |
| 06/27/2002 | US20020081742 Quantification of bitumen using NMR |
| 06/27/2002 | US20020081741 Apparatus for testing liquid/reagent mixtures |
| 06/27/2002 | US20020081740 Control liquid containing an adsorbent |
| 06/27/2002 | US20020081731 Controlling metabolite generation in plants; generate plant culture, incubate with methylation inhibitor, culture cells, maintain cells |
| 06/27/2002 | US20020081722 Nucleotide sequences coding preferential polypeptide for use in treatment and prevention of bacterial infection |
| 06/27/2002 | US20020081720 Receptor activator of NF-kappaB |
| 06/27/2002 | US20020081716 Semiconductor element and device for detecting organic molecules and method for measuring organic molecules using same |
| 06/27/2002 | US20020081715 Biomolecule microarray support, biomolecule microarray using the support, and method of fabricating the support |
| 06/27/2002 | US20020081704 Such as identifying modulators of the protease peptides for treating diseases; related to the ATP-dependent protease subfamily |
| 06/27/2002 | US20020081690 Hybrid enzyme and use thereof |
| 06/27/2002 | US20020081683 Polypeptide for use in the diagnosis and treatment of psoriasis, infection, asthma and immune and respiratory disorders |
| 06/27/2002 | US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections |
| 06/27/2002 | US20020081669 Apparatus for the amplification of nucleotide sequences |
| 06/27/2002 | US20020081663 Polypeptide for use as wound healing agent |
| 06/27/2002 | US20020081659 Nucleic acids, proteins and antibodies |
| 06/27/2002 | US20020081653 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/27/2002 | US20020081650 Expression vectors coding protein for use in the treatment of cancer, and neovascularization defects |
| 06/27/2002 | US20020081649 Peptide for use in human therapeutics and diagnostics; for use as a antitumor agent |
| 06/27/2002 | US20020081648 Peptide for use in human thereapeutics and diagnostics |